ICD Code B95.62

ICD code B95.62 is used to identify Methicillin-resistant Staphylococcus aureus (MRSA) as the cause of diseases that are classified elsewhere. This code is specifically utilized when MRSA is the underlying cause of an infection or condition that is documented in another part of the medical record. It is important for healthcare providers to accurately use this code to ensure proper documentation and billing, as well as to track the prevalence and impact of MRSA-related infections within healthcare settings.

1. Confirmed Presence of MRSA: The patient must have a confirmed laboratory diagnosis of Methicillin-resistant Staphylococcus aureus (MRSA) infection. This confirmation typically comes from a culture or other diagnostic test indicating the presence of MRSA.

2. Secondary Infection: The MRSA infection should be identified as a secondary infection that is causing or contributing to another disease or condition. This means that the MRSA is not the primary diagnosis but is influencing the course or severity of another illness.

3. Clinical Symptoms of MRSA: The patient should exhibit clinical symptoms consistent with an MRSA infection. These symptoms may include skin and soft tissue infections, such as abscesses, boils, or cellulitis, or more severe manifestations like pneumonia or bloodstream infections.

4. Resistance to Methicillin: The MRSA strain must be resistant to methicillin and potentially other beta-lactam antibiotics, which is a defining characteristic of MRSA.

5. Documentation in Medical Records: The presence of MRSA as a contributing factor to another disease must be clearly documented in the patient's medical records. This documentation should include details of the diagnostic tests performed and the clinical rationale for identifying MRSA as a cause of the secondary condition.

6. Treatment Plan: There should be a documented treatment plan addressing the MRSA infection, which may include the use of appropriate antibiotics that are effective against MRSA, such as vancomycin or linezolid.

By ensuring these criteria are met, healthcare providers can accurately use the ICD code to reflect the presence and impact of MRSA in the context of other diseases.

For the ICD code B95.62, which indicates a Methicillin-resistant Staphylococcus aureus (MRSA) infection as the cause of diseases classified elsewhere, the relevant CPT codes would depend on the specific treatment or procedure being performed to address the infection. Here are some general categories of CPT codes that might be applicable:

1. Evaluation and Management (E/M) Codes:
- 99201-99499: These codes cover office or other outpatient visits, hospital inpatient services, and consultations, which may be used for the evaluation and management of a patient with an MRSA infection.

2. Laboratory and Pathology Codes:
- 87070-87075: Culture and sensitivity tests to identify the presence of MRSA and determine appropriate antibiotic treatment.
- 87641: Infectious agent detection by nucleic acid (DNA or RNA); Staphylococcus aureus, methicillin-resistant, amplified probe technique.

3. Surgical Procedure Codes:
- 10060-10061: Incision and drainage of abscess, which may be necessary if the MRSA infection has led to abscess formation.
- 10180: Incision and drainage, complex, postoperative wound infection.

4. Antibiotic Infusion Codes:
- 96365-96367: Intravenous infusion codes for the administration of antibiotics, which may be required for treating MRSA infections.

5. Wound Care Codes:
- 97597-97598: Debridement codes for the removal of devitalized tissue from wounds infected with MRSA.

It's important to note that the selection of CPT codes should be based on the specific clinical scenario, the services provided, and the documentation in the patient's medical record. Always consult the latest CPT codebook or a coding professional for accurate coding guidance.

Discover how MD Clarity's RevFind software can enhance your revenue cycle management by accurately reading your contracts and detecting underpayments for CPT codes associated with ICD code B95.62. Schedule a demo today to see how RevFind can ensure you're receiving the full reimbursement you deserve.